NEW YORK, Dec. 8, 2015 /PRNewswire/ -- The article
excerpt below from Global Health & Pharma (GHP) Magazine,
written by Richie Etwaru, chief
digital officer, IMS Health looks at the significant impact that
technology will have on three critical aspects of the
pharmaceutical sales representative's role both now and in the
future.
ARTICLE EXCERPT:
The future viability of the current pharmaceutical sales force
model ranges from a doomsday scenario of no more pharmaceutical
sales representatives at all to predictions of a return to the
glory days where the pharmaceutical sales representative was at the
center of the brand-commercialization universe.
It's safe to say that the only certainty regarding the
pharmaceutical sales model is uncertainty.
One thing is for sure, there will be change and that continued
change will be increasingly fueled by technology.
In fact, advancing technology promises to transform the role of
the pharmaceutical sales representatives into a critical linchpin
within the overall commercial strategy of a brand – elevating
customer engagement via three differentiating factors of high
transparency, high context and high touch.
To view the entire article as it appears on Global Health &
Pharma Magazine click here and scroll to page 13:
http://issuu.com/aiglobalmedia/docs/ghp_october_2015
About IMS Health
IMS Health (NYSE:IMS) is a leading global information and
technology services company providing clients in the healthcare
industry with end-to-end solutions to measure and improve their
performance. Our 7,500 services experts connect configurable SaaS
applications to 10+ petabytes of complex healthcare data in
the IMS One™ cloud platform, delivering unique insights
into diseases, treatments, costs and outcomes. The company's 15,000
employees blend global consistency and local market knowledge
across 100 countries to help clients run their operations more
efficiently. Customers include pharmaceutical, consumer health and
medical device manufacturers and distributors, providers, payers,
government agencies, policymakers, researchers and the financial
community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available
at www.imshealth.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ghp-magazine-3-ways-that-technology-can-future-proof-the-pharma-sales-force-today-300189522.html
SOURCE IMS Health